FIRE AND ICE
2016
Fire and Ice Trial: Cryoballoon versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
In 762 patients with drug-refractory paroxysmal atrial fibrillation, cryoballoon ablation was non-inferior for clinical treatment failure compared with radiofrequency ablation.
Result
Efficacy: First clinical failure (recurrent AF, flutter/tachycardia, AAD use, or repeat ablation) after 90-day blankingHR 0.96 (95% CI 0.76-1.22) · P < 0.001
Below 1 favours cryoballoon ablation, above 1 favours radiofrequency ablation.
- Absolute difference
- 1.3 points
The absolute difference is derived from the event rates.
Also reported: Cryoballoon non-inferior to radiofrequency; safety similar.
- Subtopic
- Ablation
- Design
- Multicentre open-label non-inferiority RCT
- Relevance
- Supporting: context rather than must-know.
- Cited in
- ACC/AHA 2023 AF
- Source
- Kuck KH, et al. N Engl J Med. 2016;374(23):2235-2245.doi 10.1056/NEJMoa1602014
Discussion & critique
Restricted to paroxysmal AF and used first-generation as well as newer cryoballoons, limiting generalisability. Validated cryoballoon ablation as an efficient, reproducible alternative to point-by-point radiofrequency.